CLPT ClearPoint Neuro Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 3, 2026
$10.90
· of 52w range
· above low
· to high
$8.2752w low
$30.1052w high
Market Cap (MRQ)
$332M
P/E (TTM)
-9.3
EPS (TTM)
$-1.17
Revenue (TTM)
$42M
your badges
52W Range
$8–$30
Analyst Rating
BUY
Price Target
$24
P/E
-9.3
ROE
-226.5%
Net Profit Margin
-81.8%
Your badge strip is empty — pin a metric anywhere on this page.
CLPT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.89
Market Cap (MRQ)
$332M
P/E (TTM)
-9.3
EPS (TTM)
$-1.17
Revenue (TTM)
$42M
ROE (TTM)
-226.5%
52W Range
$8–$30
CLPT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| July 27, 2016 | 1-for-40 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$37M2016-12-31 → 2025-12-31
EPS$-0.902021-12-31 → 2025-12-31
Free Cash Flow$-24M2017-12-31 → 2025-12-31
Net margin-81.8%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CLPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -9.35Y avg ≈-14.7 | ≈-14.7 | · | · | |
| P/S (TTM) | 7.95Y avg ≈11.6 | ≈11.6 | 5.0 | Overvalued | |
| P/B (MRQ) | 30.85Y avg ≈10.0 | ≈10.0 | 3.5 | Overvalued | |
| Price / FCF (TTM) | -10.65Y avg ≈-21.5 | ≈-21.5 | · | · | |
| Price / Cash Flow (TTM) | -11.05Y avg ≈-22.0 | ≈-22.0 | · | · | |
| Price / Tangible Book (MRQ) | -155.45Y avg ≈19.3 | ≈19.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CLPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 62.6%5Y avg ≈62.8% | ≈62.8% | 76.5% | Weak | |
| Operating Margin (TTM) | -73.4%5Y avg ≈-76.7% | ≈-76.7% | -45.6% | Weak | |
| EBITDA Margin (TTM) | -72.1%5Y avg ≈-74.7% | ≈-74.7% | -45.6% | Weak | |
| Pretax Margin (TTM) | -81.8% | · | -33.1% | Weak | |
| Net Profit Margin (TTM) | -81.8%5Y avg ≈-78.0% | ≈-78.0% | -45.2% | Weak | |
| ROA (TTM) | -46.2%5Y avg ≈-37.2% | ≈-37.2% | -30.8% | Weak | |
| ROE (TTM) | -226.5%5Y avg ≈-69.6% | ≈-69.6% | -85.4% | Below avg | |
| ROIC | -86.4% | · | -15.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CLPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.75Y avg ≈6.9 | ≈6.9 | 4.4 | In line | |
| Quick Ratio | 4.95Y avg ≈5.7 | ≈5.7 | 2.9 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CLPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 17.8%5Y avg ≈23.7% | ≈23.7% | · | · | |
| Revenue CAGR 3Y | 21.6%5Y avg ≈23.1% | ≈23.1% | · | · | |
| Revenue CAGR 5Y | 23.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CLPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.5 | ≈0.5 | 0.7 | Weak | |
| Inventory Turnover | 1.95Y avg ≈1.4 | ≈1.4 | 1.7 | In line | |
| Receivables Turnover | 6.65Y avg ≈7.7 | ≈7.7 | 6.3 | In line | |
| Revenue / Employee | ≈$231.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-19.0%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $-0.38 | $-0.29 | -30.0% |
| March 31, 2026 | May 13, 2026 | $-0.32 | $-0.28 | -14.8% |
| Dec. 31, 2025 | $-0.26 | $-0.20 | -27.5% | |
| Sept. 30, 2025 | $-0.21 | $-0.20 | -2.9% | |
| June 30, 2025 | $-0.21 | $-0.20 | -2.9% | |
| March 31, 2025 | $-0.22 | $-0.16 | -34.8% | |
| Dec. 31, 2024 | $-0.20 | $-0.17 | -20.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37M | $31M | $24M | $21M | $16M | $13M | $11M | $7M | $7M | $6M | $5M | $4M | |
| Cost of Revenue | $14M | $12M | $10M | $7M | $5M | $4M | $4M | $2M | $3M | $3M | $2M | $2M | |
| Gross Profit | $23M | $19M | $14M | $14M | $11M | $9M | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $12M | $11M | $9M | $5M | $3M | $2M | $3M | $3M | $2M | $3M | |
| SG&A Expense | $16M | $12M | $12M | $10M | $8M | $5M | $4M | $4M | $4M | $4M | $8M | $8M | |
| Operating Income | $-24M | $-20M | $-22M | $-16M | $-13M | $-6M | $-5M | $-5M | $-6M | $-7M | $-9M | $-5M | |
| Interest Expense | · | · | · | $81.0K | $973.0K | $1M | $955.0K | $980.4K | $872.9K | $1M | $1M | $1M | |
| Interest Income | $1M | $1M | · | · | · | · | · | · | · | $8.8K | $16.5K | $11.6K | |
| Other Non-op | $-146.0K | $-40.0K | $-29.0K | $-22.0K | $-63.0K | $882.0K | $9.0K | $364 | $16.7K | $216.1K | $230.9K | $175.5K | |
| Pretax Income | $-25M | $-19M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $55.0K | $12.0K | $8.0K | $0 | $0 | $0 | · | · | · | · | · | $0 | |
| Net Income | $-26M | $-19M | $-22M | $-16M | $-14M | $-7M | $-6M | $-6M | $-7M | $-8M | $-8M | $-5M | |
| EPS (Basic) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 | · | · | · | · | · | · | · | |
| Shares (Basic) | 28,315,254 | 27,027,692 | 24,605,212 | 24,181,854 | 20,734,236 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 28,315,254 | 27,027,692 | 24,605,212 | 24,181,854 | 20,734,236 | · | · | · | · | · | · | · | |
| EBITDA | $-23M | $-19M | $-22M | $-16M | $-13M | $-6M | $-4M | $-5M | $-6M | · | $-9M | $-5M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $20M | $23M | $28M | $54M | $20M | $6M | $3M | $9M | $3M | $5M | $9M | |
| Short-term Investments | · | · | $0 | $10M | $0 | · | · | · | · | · | · | · | |
| Receivables | $7M | $5M | $3M | $3M | $2M | $2M | $1M | $1M | $949.4K | $865.9K | $1M | $468.9K | |
| Inventory | $8M | $7M | $8M | $9M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $3M | $2M | $2M | $2M | $508.0K | $244.0K | $358.0K | $213.7K | $192.7K | $135.0K | $97.2K | $29.2K | |
| Current Assets | $64M | $33M | $36M | $51M | $62M | $25M | $10M | $7M | $13M | $6M | $9M | $12M | |
| PP&E (Net) | $3M | $2M | $1M | $806.0K | $539.0K | $319.0K | $447.0K | $377.7K | $267.7K | $328.2K | $440.6K | $483.0K | |
| PP&E (Gross) | $4M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $945.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Goodwill | $7M | $7M | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $14M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $735.0K | $109.0K | $131.0K | $125.0K | $59.0K | $218.0K | $22.5K | $11.6K | $10.6K | $27.3K | $285.5K | |
| Total Assets | $98M | $39M | $43M | $55M | $66M | $30M | $12M | $8M | $14M | $7M | $10M | $13M | |
| Accounts Payable | $1M | $1M | $393.0K | $272.0K | $427.0K | $300.0K | $966.0K | $500.9K | $759.4K | $2M | $697.8K | $997.1K | |
| Current Liabilities | $11M | $10M | $7M | $7M | $5M | $3M | $4M | $2M | $4M | $3M | $8M | $5M | |
| Capital Leases | $8M | $3M | $4M | $2M | $2M | $2M | $277.0K | · | · | · | · | · | |
| Deferred Tax | $354.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $489.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $70M | $14M | $21M | $19M | $17M | $27M | $7M | $6M | $8M | $8M | $12M | $13M | |
| Long-term Debt | $49M | · | $10M | $10M | $10M | $21M | $2M | $3M | $5M | $4M | $8M | $11M | |
| Common Stock | $294.0K | $276.0K | $247.0K | $246.0K | $237.0K | $170.0K | $152.0K | $110.2K | $106.9K | $36.2K | $22.8K | $748.4K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $76M | |
| Retained Earnings | $-217M | $-191M | $-172M | $-150M | $-134M | $-120M | $-113M | $-107M | $-101M | $-94M | $-86M | $-77M | |
| Stockholders' Equity | $28M | $25M | $21M | $37M | $49M | $2M | $5M | $2M | $6M | $-756.1K | $-2M | $-100.3K | |
| Liabilities + Equity | $98M | $39M | $43M | $55M | $66M | $30M | $12M | $8M | $14M | $7M | $10M | $13M | |
| Shares Outstanding | 29,368,760 | 27,617,415 | 24,652,729 | 24,578,983 | 23,665,991 | 17,047,584 | 15,235,308 | 11,018,364 | 10,693,851 | 3,622,032 | 2,284,537 | 74,842,428 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $814.0K | $980.0K | $626.0K | $244.0K | $159.0K | $334.0K | $144.0K | $109.4K | $116.5K | $155.7K | $211.9K | $377.3K | |
| Stock-based Comp | $8M | $7M | $6M | $4M | $2M | $1M | $799.0K | $1M | $1M | $1M | $2M | $880.8K | |
| Amort. of Intangibles | $168.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $1M | · | |
| Other Non-cash | $-7M | $2M | $2M | $-4M | $-524.0K | $-2M | $2M | $192.1K | $-187.2K | · | $-2M | $-4M | |
| Operating Cash Flow | $-24M | $-9M | $-14M | $-16M | $-13M | $-8M | $-3M | $-5M | $-6M | $-6M | $-9M | $-7M | |
| CapEx | $522.0K | $275.0K | $717.0K | $253.0K | $168.0K | $41.0K | $10.0K | $63.5K | $26.8K | $101.0K | $76.9K | $48.1K | |
| Investing Cash Flow | $615.0K | $-275.0K | $9M | $-11M | $-168.0K | $-482.0K | $-160.0K | $-63.5K | $-26.8K | $-101.0K | · | $-48.1K | |
| Stock Issued | $3M | $16M | $0 | $0 | $47M | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $3M | $16M | · | $0 | $47M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50M | $6M | $296.0K | $409.0K | $47M | $23M | $6M | $-1M | $12M | $4M | · | $13M | |
| Net Change in Cash | $27M | $-3M | $-4M | $-26M | $34M | $14M | $3M | $-6M | $6M | $-2M | $-4M | $6M | |
| Free Cash Flow | $-24M | $-9M | $-14M | $-16M | $-13M | $-8M | $-3M | $-5M | $-6M | · | $-9M | $-7M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.4% | 60.9% | 56.8% | 65.8% | 69.3% | · | · | · | · | · | · | · | |
| Operating Margin | -65.4% | -62.9% | -93.7% | -79.5% | -82.0% | -48.5% | -40.9% | -71.4% | -85.9% | · | -195.3% | -147.6% | |
| Net Margin | -69.1% | -60.2% | -92.2% | -80.0% | -88.4% | -52.9% | -49.4% | -83.8% | -97.1% | · | -183.9% | -125.5% | |
| Pretax Margin | -68.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -63.2% | -59.8% | -91.1% | -78.3% | -81.1% | -45.9% | -39.7% | -69.9% | -84.3% | · | -190.7% | -137.1% | |
| ROA | -37.3% | -46.2% | -45.0% | -27.2% | -30.3% | -32.7% | -56.0% | -56.7% | -67.3% | · | -71.9% | -42.6% | |
| ROE | -106.9% | -69.5% | -97.6% | -42.8% | -31.0% | -537.0% | -104.6% | -307.9% | -282.6% | · | 811.8% | 130.5% | |
| ROIC | -86.4% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.2 | 4.9 | 7.5 | 13.0 | 8.0 | 2.7 | 3.3 | 2.9 | · | 1.1 | · | |
| Quick Ratio | 4.9 | 2.4 | 3.5 | 5.9 | 11.9 | 6.9 | 1.8 | 2.2 | 2.3 | · | 0.9 | · | |
| Interest Coverage | · | · | · | -201.6 | -13.7 | -4.3 | -4.8 | -5.4 | -7.3 | · | -7.1 | -5.2 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.8 | 0.5 | 0.3 | 0.3 | 0.6 | 1.1 | 0.7 | 0.7 | · | 0.4 | 0.3 | |
| Inventory Turnover | 1.9 | 1.7 | 1.2 | 1.0 | 1.2 | 1.1 | 1.4 | 1.1 | 1.4 | · | 1.1 | 1.1 | |
| Receivables Turnover | 6.6 | 7.9 | 8.2 | 8.2 | 7.7 | 8.6 | 9.7 | 6.7 | 8.1 | · | 5.4 | 5.8 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.95 | $0.92 | $0.86 | $1.50 | $2.06 | $0.14 | $0.30 | $0.14 | $0.55 | · | $-0.02 | $-0.00 | |
| Revenue / Share | $1.31 | $1.16 | $0.97 | $0.85 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.84 | $-0.33 | $-0.56 | $-0.67 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.56 | $0.73 | $0.94 | $1.12 | $2.29 | $1.18 | $0.37 | $0.28 | $0.87 | · | $0.06 | $0.12 | |
| EPS (TTM) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 | · | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.8% | 31.0% | 16.6% | 26.1% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 21.6% | 24.4% | 23.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 23.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $31M | $24M | $21M | $16M | $13M | $11M | $7M | $7M | $6M | $5M | $4M | |
| Net Income TTM | $-26M | $-19M | $-22M | $-16M | $-14M | $-7M | $-6M | $-6M | $-7M | $-8M | $-8M | $-5M | |
| Market Cap | $402M | $425M | $167M | $208M | $266M | $271M | $73M | $17M | $29M | · | $1.39B | $2.48B | |
| P/E | -15.2 | -22.0 | -7.5 | -12.5 | -16.3 | · | · | · | · | · | · | · | |
| P/S | 10.9 | 13.5 | 7.0 | 10.1 | 16.3 | 21.1 | 6.5 | 2.4 | 4.0 | · | 302.3 | 689.4 | |
| P/B | 14.3 | 16.7 | 7.9 | 5.6 | 5.4 | 114.0 | 15.9 | 11.4 | 5.0 | · | -701.1 | -24766.0 | |
| P / Tangible Book | 60.6 | 16.7 | 7.9 | 5.6 | 5.4 | 114.0 | · | · | · | · | · | · | |
| P / Cash Flow | -16.8 | -47.5 | -12.2 | -12.9 | -20.9 | -34.7 | -25.7 | -3.7 | -4.9 | · | -160.8 | -342.7 | |
| P / FCF | -16.4 | -46.0 | -11.6 | -12.7 | -20.6 | -34.5 | -25.6 | -3.7 | -4.9 | · | -159.4 | -340.5 | |
| Earnings Yield | -6.6% | -4.5% | -13.2% | -8.0% | -6.2% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $7M | $6M | $6M | $5M | $5M | $5M | |
| Cost of Revenue | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $1M | |
| Gross Profit | $7M | $8M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $4M | |
| R&D Expense | $5M | $5M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | |
| SG&A Expense | $6M | $5M | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Income | $-10M | $-8M | $-7M | $-5M | $-6M | $-6M | $-6M | $-5M | $-5M | $-4M | $-5M | $-5M | $-7M | $-6M | $-4M | $-4M | |
| Interest Income | $289.0K | $351.0K | · | · | $285.0K | $151.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-7.0K | $-35.0K | $-34.0K | $-64.0K | $-52.0K | $4.0K | $-8.0K | $-11.0K | $5.0K | $-26.0K | $-4.0K | $-12.0K | $-2.0K | $-11.0K | $0 | $-25.0K | |
| Pretax Income | $-11M | $-10M | $-8M | $-6M | $-6M | $-6M | $-5M | $-5M | $-4M | $-4M | · | · | · | · | · | · | |
| Income Tax | $-38.0K | $8.0K | $4.0K | $8.0K | $25.0K | $18.0K | $-32.0K | $14.0K | $15.0K | $15.0K | · | · | · | · | · | · | |
| Net Income | $-11M | $-10M | $-8M | $-6M | $-6M | $-6M | $-5M | $-5M | $-4M | $-4M | $-5M | $-5M | $-7M | $-6M | $-4M | $-4M | |
| EPS (Basic) | $-0.38 | $-0.32 | $-0.26 | $-0.21 | $-0.21 | $-0.22 | $-0.20 | $-0.18 | $-0.16 | $-0.16 | $-0.18 | $-0.20 | $-0.29 | $-0.23 | $-0.18 | $-0.15 | |
| EPS (Diluted) | $-0.38 | $-0.32 | $-0.26 | $-0.21 | $-0.21 | $-0.22 | $-0.20 | $-0.18 | $-0.16 | $-0.16 | $-0.18 | $-0.20 | $-0.29 | $-0.23 | $-0.18 | $-0.15 | |
| Shares (Basic) | 30,166,640 | 29,546,889 | · | 28,427,574 | 28,258,305 | 27,718,918 | · | 27,591,623 | 27,468,378 | 25,452,096 | · | 24,630,181 | 24,583,712 | 24,583,163 | · | 24,497,636 | |
| Shares (Diluted) | 30,166,640 | 29,546,889 | · | 28,427,574 | 28,258,305 | 27,718,918 | · | 27,591,623 | 27,468,378 | 25,452,096 | · | 24,630,181 | 24,583,712 | 24,583,163 | · | 24,497,636 | |
| EBITDA | $-10M | $-8M | · | $-5M | $-6M | $-6M | · | $-5M | $-5M | $-4M | · | $-5M | $-7M | $-6M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $36M | $46M | $38M | $42M | $12M | $20M | $22M | $33M | $35M | $23M | $24M | $26M | $22M | $28M | $19M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $10M | $10M | $22M | |
| Receivables | $8M | $9M | $7M | $4M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | |
| Inventory | $9M | $9M | $8M | $7M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $9M | $8M | |
| Prepaid Expense | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Assets | $49M | $55M | $64M | $51M | $54M | $24M | $33M | $34M | $47M | $48M | $36M | $37M | $41M | $46M | $51M | $54M | |
| PP&E (Net) | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $949.0K | $806.0K | $629.0K | |
| PP&E (Gross) | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $1M | · | · | · | $945.0K | · | · | · | $2M | · | |
| Goodwill | $7M | $7M | $7M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Intangibles | $13M | $13M | $14M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $959.0K | $720.0K | $148.0K | $735.0K | $148.0K | $149.0K | $149.0K | $109.0K | $109.0K | $156.0K | $131.0K | $131.0K | $94.0K | |
| Total Assets | $87M | $93M | $98M | $60M | $63M | $30M | $39M | $40M | $53M | $54M | $43M | $44M | $48M | $50M | $55M | $58M | |
| Accounts Payable | $2M | $2M | $1M | $723.0K | $2M | $1M | $1M | $955.0K | $822.0K | $844.0K | $393.0K | $789.0K | $1M | $1M | $272.0K | $1M | |
| Current Liabilities | $10M | $9M | $11M | $8M | $7M | $7M | $10M | $8M | $17M | $15M | $7M | $6M | $6M | $6M | $7M | $6M | |
| Capital Leases | $14M | $14M | $8M | $6M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $1M | $2M | $2M | |
| Deferred Tax | $321.0K | $354.0K | $354.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $1M | $779.0K | $489.0K | $263.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $76M | $75M | $70M | $44M | $43M | $10M | $14M | $11M | $20M | $19M | $21M | $20M | $20M | $18M | $19M | $18M | |
| Long-term Debt | $50M | $50M | $49M | $29M | $29M | · | · | · | $10M | $10M | · | $10M | $10M | $10M | · | $10M | |
| Common Stock | $305.0K | $300.0K | $294.0K | $284.0K | $284.0K | $280.0K | $276.0K | $276.0K | $276.0K | $274.0K | $247.0K | $246.0K | $246.0K | $246.0K | $246.0K | $245.0K | |
| Retained Earnings | $-238M | $-226M | $-217M | $-209M | $-203M | $-197M | $-191M | $-186M | $-181M | $-177M | $-172M | $-168M | $-163M | $-156M | $-150M | $-146M | |
| Stockholders' Equity | $11M | $19M | $28M | $16M | $20M | $20M | $25M | $29M | $32M | $35M | $21M | $24M | $27M | $33M | $37M | $40M | |
| Liabilities + Equity | $87M | $93M | $98M | $60M | $63M | $30M | $39M | $40M | $53M | $54M | $43M | $44M | $48M | $50M | $55M | $58M | |
| Shares Outstanding | 30,503,132 | 29,986,639 | 29,368,760 | 28,428,176 | 28,423,611 | 27,980,184 | 27,617,415 | 27,588,819 | 27,588,812 | 27,416,345 | 24,652,729 | 24,625,670 | 24,627,674 | 24,582,251 | 24,578,983 | 24,500,832 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $150.0K | $86.0K | $249.0K | $66.0K | $396.0K | $103.0K | $240.0K | $264.0K | $233.0K | $243.0K | $183.0K | $158.0K | $156.0K | $129.0K | $20.0K | $37.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Amort. of Intangibles | $503.0K | $504.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-719.0K | · | · | · | $-2M | · | · | · | $-1M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-7M | $-8M | $-12M | $-3M | $-3M | $-6M | $-1M | $-1M | $-3M | $-4M | $-1M | $-2M | $-5M | $-6M | $-3M | $-4M | |
| CapEx | $214.0K | $645.0K | $49.0K | $199.0K | $91.0K | $183.0K | $263.0K | $12.0K | $0 | $0 | $21.0K | $235.0K | $323.0K | $138.0K | $39.0K | $69.0K | |
| Investing Cash Flow | $-214.0K | $-645.0K | $1M | $-199.0K | $-91.0K | $-183.0K | $-263.0K | $-12.0K | $0 | $0 | $-188.0K | $-235.0K | $10M | $-138.0K | $12M | $-631.0K | |
| Stock Issued | · | · | $0 | $0 | $3M | $0 | $-34.0K | $0 | $0 | $16M | $0 | $0 | $0 | $0 | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $16M | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $-2M | $20M | $0 | $32M | $-1M | $37.0K | $-10M | $160.0K | $16M | $155.0K | $-91.0K | $237.0K | $-5.0K | $222.0K | $-329.0K | |
| Net Change in Cash | $-6M | $-10M | $9M | $-3M | $29M | $-8M | $-1M | $-11M | $-3M | $12M | $-1M | $-2M | $5M | $-6M | $9M | $-5M | |
| Free Cash Flow | · | $-9M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | $-6M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.7% | 63.9% | · | 63.2% | 60.3% | 60.5% | · | 59.7% | 63.5% | 59.2% | · | 56.8% | 52.5% | 58.9% | · | 72.1% | |
| Operating Margin | -94.2% | -69.9% | · | -59.5% | -61.6% | -72.6% | · | -63.7% | -60.3% | -55.4% | · | -85.0% | -119.8% | -105.1% | · | -73.8% | |
| Net Margin | -104.2% | -78.8% | · | -66.5% | -63.3% | -71.0% | · | -61.2% | -56.1% | -54.3% | · | -83.5% | -118.5% | -103.2% | · | -73.6% | |
| Pretax Margin | -104.6% | -78.7% | · | -66.4% | -63.1% | -70.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -94.2% | -69.2% | · | -59.5% | -61.6% | -71.4% | · | -63.7% | -60.3% | -52.2% | · | -85.0% | -119.8% | -102.8% | · | -73.8% | |
| ROA | -15.2% | -15.5% | · | -11.7% | -10.1% | -14.4% | · | -11.8% | -8.8% | -8.0% | · | -9.5% | -13.1% | -10.0% | · | -6.0% | |
| ROE | -74.3% | -49.2% | · | -26.3% | -22.5% | -22.1% | · | -18.7% | -14.8% | -12.3% | · | -15.0% | -20.1% | -14.3% | · | -9.0% | |
| ROIC | -94.8% | -45.0% | · | -33.3% | -28.9% | -30.9% | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.8 | · | 6.4 | 7.3 | 3.5 | · | 4.5 | 2.8 | 3.1 | · | 6.7 | 6.6 | 7.6 | · | 8.8 | |
| Quick Ratio | 3.7 | 4.7 | · | 5.2 | 6.2 | 2.3 | · | 3.4 | 2.2 | 2.5 | · | 4.8 | 4.7 | 5.7 | · | 7.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.3 | · | 0.2 | |
| Receivables Turnover | 1.7 | 2.0 | · | 2.3 | 2.4 | 2.8 | · | 2.6 | 2.5 | 2.9 | · | 2.0 | 1.9 | 2.2 | · | 1.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.63 | · | $0.56 | $0.69 | $0.71 | · | $1.05 | $1.16 | $1.26 | · | $0.98 | $1.11 | $1.33 | · | $1.63 | |
| Revenue / Share | $0.36 | $0.41 | · | $0.31 | $0.33 | $0.31 | · | $0.29 | $0.29 | $0.30 | · | $0.23 | $0.24 | $0.22 | · | $0.21 | |
| Cash Flow / Share | · | $-0.27 | · | · | · | $-0.22 | · | · | · | $-0.15 | · | · | · | $-0.23 | · | · | |
| Cash / Share | $0.96 | $1.19 | · | $1.34 | $1.46 | $0.44 | · | $0.78 | $1.19 | $1.29 | · | $0.99 | $1.07 | $0.89 | · | $0.76 | |
| EPS (TTM) | $-1.17 | $-1.00 | · | $-0.84 | $-0.81 | $-0.76 | · | $-0.68 | $-0.70 | $-0.83 | · | $-0.90 | $-0.85 | $-0.74 | · | $-0.71 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $41M | · | $34M | $34M | $32M | · | $30M | $28M | $26M | · | $22M | $22M | $21M | · | $20M | |
| Net Income TTM | $-35M | $-29M | · | $-23M | $-22M | $-21M | · | $-18M | $-18M | $-21M | · | $-22M | $-21M | $-18M | · | $-16M | |
| Market Cap | $544M | $273M | · | $619M | $339M | $333M | · | $309M | $149M | $186M | · | $123M | $178M | $207M | · | $254M | |
| P/E | -15.2 | -9.1 | · | -25.9 | -14.7 | -15.6 | · | -16.5 | -7.7 | -8.2 | · | -5.6 | -8.5 | -11.4 | · | -14.6 | |
| P/S | 12.9 | 6.7 | · | 18.0 | 10.1 | 10.3 | · | 10.2 | 5.3 | 7.1 | · | 5.5 | 8.2 | 9.9 | · | 12.9 | |
| P/B | 50.5 | 14.5 | · | 39.0 | 17.2 | 16.6 | · | 10.7 | 4.6 | 5.4 | · | 5.1 | 6.5 | 6.4 | · | 6.4 | |
| P / Tangible Book | · | · | · | 39.0 | 17.2 | 16.6 | · | 10.7 | 4.6 | 5.4 | · | 5.1 | 6.5 | 6.4 | · | 6.4 | |
| P / Cash Flow | · | -34.3 | · | · | · | -53.9 | · | · | · | -48.5 | · | · | · | -36.5 | · | · | |
| Earnings Yield | -6.6% | -11.0% | · | -3.9% | -6.8% | -6.4% | · | -6.1% | -13.0% | -12.2% | · | -18.0% | -11.7% | -8.8% | · | -6.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $37M | $31M | $24M | $21M | $16M |
| Gross Margin % | 61.4% | 60.9% | 56.8% | 65.8% | 69.3% |
| Operating Margin % | -65.4% | -62.9% | -93.7% | -79.5% | -82.0% |
| Net Income | $-26M | $-19M | $-22M | $-16M | $-14M |
| Diluted EPS | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.2 | 4.9 | 7.5 | 13.0 |
| Quick Ratio | 4.9 | 2.4 | 3.5 | 5.9 | 11.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-24M | $-9M | $-14M | $-16M | $-13M |
Institutional owners (13F) 144 filers · $287.0M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
144
Value held
$287.0M
New positions
22
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 22 (-7 vs prior Q) | 12 (-8 vs prior Q) | 50 (+6 vs prior Q) | 32 (+8 vs prior Q) | +980K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $42,455,704 | 2,379,804 | 14.80% | Shares |
| MAK CAPITAL ONE LLC | $42,385,360 | 2,375,861 | 14.77% | Shares |
| VANGUARD GROUP INC | $24,168,142 | 1,766,677 | 8.42% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $21,993,277 | 1,232,807 | 7.66% | Shares |
| STATE STREET CORP | $14,567,198 | 816,547 | 5.08% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $13,382,449 | 749,932 | 4.66% | Shares |
| Lane Generational LLC | $7,935,785 | 444,831 | 2.77% | Shares |
| UBS Group AG | $7,646,795 | 428,632 | 2.66% | Shares |
| MILLENNIUM MANAGEMENT LLC | $6,380,940 | 357,676 | 2.22% | Shares |
| BROWN ADVISORY INC | $5,814,163 | 325,906 | 2.03% | Shares |
| JANE STREET GROUP, LLC | $4,401,128 | 246,700 | 1.53% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4,286,631 | 240,282 | 1.49% | Shares |
| NORTHERN TRUST CORP | $4,120,790 | 230,986 | 1.44% | Shares |
| Pier Capital, LLC | $3,974,056 | 222,761 | 1.38% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $3,804,309 | 213,246 | 1.33% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,471,379 | 194,584 | 1.21% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,214,768 | 180,200 | 1.12% | Call option |
| TUDOR INVESTMENT CORP ET AL | $3,099,861 | 173,759 | 1.08% | Shares |
| MORGAN STANLEY | $2,957,621 | 165,786 | 1.03% | Shares |
| Cahill Wealth Management, LLC | $2,917,176 | 245,347 | 1.02% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,762,542 | 154,851 | 0.96% | Shares |
| Bank of New York Mellon Corp | $2,707,522 | 151,767 | 0.94% | Shares |
| PARSONS CAPITAL MANAGEMENT INC/RI | $2,657,732 | 148,976 | 0.93% | Shares |
| Pekin Hardy Strauss, Inc. | $2,557,810 | 143,375 | 0.89% | Shares |
| GOLDMAN SACHS GROUP INC | $2,478,172 | 138,911 | 0.86% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,411,968 | 135,200 | 0.84% | Put option |
| Taylor Frigon Capital Management LLC | $2,355,041 | 132,009 | 0.82% | Shares |
| CITADEL ADVISORS LLC | $2,299,576 | 128,900 | 0.80% | Call option |
| CM Management, LLC | $2,230,000 | 125,000 | 0.78% | Shares |
| Diametric Capital, LP | $2,199,547 | 123,293 | 0.77% | Shares |
| FirstWave Capital Management LLC | $2,062,304 | 115,600 | 0.72% | Shares |
| DEUTSCHE BANK AG\ | $2,047,943 | 114,795 | 0.71% | Shares |
| Financial Engines Advisors L.L.C. | $1,873,789 | 105,033 | 0.65% | Shares |
| Longaeva Partners L.P. | $1,693,194 | 94,910 | 0.59% | Shares |
| CONWAY CAPITAL MANAGEMENT, INC. | $1,658,674 | 92,975 | 0.58% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,605,315 | 89,984 | 0.56% | Shares |
| Exome Asset Management LLC | $1,492,066 | 83,636 | 0.52% | Shares |
| Quantinno Capital Management LP | $1,440,705 | 80,757 | 0.50% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,397,800 | 78,352 | 0.49% | Shares |
| JANE STREET GROUP, LLC | $1,380,816 | 77,400 | 0.48% | Put option |
| Nuveen, LLC | $1,302,142 | 72,990 | 0.45% | Shares |
| LPL Financial LLC | $1,220,095 | 68,391 | 0.43% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,213,975 | 68,048 | 0.42% | Shares |
| TWO SIGMA ADVISERS, LP | $989,064 | 72,300 | 0.34% | Shares |
| MILLENNIUM MANAGEMENT LLC | $933,032 | 52,300 | 0.33% | Call option |
| Massar Capital Management, LP | $896,960 | 50,278 | 0.31% | Shares |
| NAVELLIER & ASSOCIATES INC | $892,000 | 50,000 | 0.31% | Shares |
| CITADEL ADVISORS LLC | $868,594 | 48,688 | 0.30% | Shares |
| CITADEL ADVISORS LLC | $806,368 | 45,200 | 0.28% | Put option |
| WOLVERINE TRADING, LLC | $718,281 | 33,300 | 0.25% | Call option |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. ×5 filings | Aug. 27, 2024 | · | Initial filing | · | SEC |
| Bruce C. Conway ×4 filings | June 5, 2017 | · | Initial filing | Passive investment | SEC |
| Voyager Therapeutics, Inc. (2) | Sept. 12, 2016 | · | Initial filing | · | SEC |
| SS. OR | July 7, 2014 | · | Initial filing | · | SEC |
| I. R.S. Identification Nos. of above persons ( entities only ). Bruce C. Conway | June 19, 2014 | · | Initial filing | Passive investment | SEC |
| Andrew K. Rooke | May 21, 2012 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 30 insiders · 12 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joseph Burnett | CEO and President | Sept. 2, 2026 M | 130,720 | 0 | 10 | $-2,872,963 |
| Francis P Grillo | CHIEF EXECUTIVE OFFICER | Nov. 7, 2017 A | 147,724 | 0 | 0 | $0 |
| Danilo D'Alessandro | Chief Financial Officer | June 30, 2026 A | 103,769 | 0 | 0 | $0 |
| Harold A Hurwitz | Chief Financial Officer | July 9, 2020 A | 36,331 | 0 | 0 | $0 |
| David W. Carlson | Chief Financial Officer | Nov. 5, 2013 A | · | 0 | 0 | $0 |
| Mazin Sabra | Chief Operating Officer | March 12, 2026 M | 67,343 | 0 | 0 | $0 |
| Peter G. Piferi | Chief Operating Officer | Aug. 20, 2021 A | 68,739 | 0 | 0 | $0 |
| Jeremy L. Stigall | Chief Business Officer | June 30, 2026 A | 110,263 | 0 | 0 | $0 |
| Wendelin C Maners | Vice President, Marketing | Oct. 4, 2017 A | 38,900 | 0 | 0 | $0 |
| Robert C. Korn | Vice President, Sales | Aug. 13, 2015 A | · | 0 | 0 | $0 |
| Oscar L. Thomas | VP Business Affairs | April 13, 2012 A | · | 0 | 0 | $0 |
| Carol J. Barbre | VP Product Management | April 13, 2012 A | · | 0 | 0 | $0 |
| Timothy T. Richards | Director | Oct. 1, 2026 A | 87,863 | 0 | 1 | $-65,901 |
| John R Fletcher | Director | Oct. 1, 2026 A | 132,004 | 0 | 0 | $0 |
| Linda M. Liau | Director | May 21, 2026 A | 64,801 | 0 | 0 | $0 |
| Matthew B. Klein | Director | May 21, 2026 A | 46,935 | 0 | 1 | $-185,440 |
| Kristine B Johnson | Director | May 21, 2026 A | 71,116 | 0 | 0 | $0 |
| Lynnette C Fallon | Director | May 21, 2026 A | 48,227 | 0 | 1 | $-56,714 |
| Pascal E R Girin | Director | May 19, 2026 M | 110,623 | 0 | 0 | $0 |
| John N Spencer JR | Director | March 31, 2021 A | 24,361 | 0 | 0 | $0 |
| Kimble L. Jenkins | Director | Dec. 31, 2020 A | 49,251 | 0 | 0 | $0 |
| Maria Sainz | Director | March 30, 2018 A | 918 | 0 | 0 | $0 |
| Charles E Koob | Director | Oct. 4, 2017 A | 22,902 | 0 | 0 | $0 |
| Philip A. Pizzo | Director | Dec. 30, 2016 A | 5,625 | 0 | 0 | $0 |
| Andrew K. Rooke | Director | Dec. 30, 2016 A | 27,982 | 0 | 0 | $0 |
| Michael J. Ryan | Director | March 31, 2015 A | 30,055 | 0 | 0 | $0 |
| Michael Pietrangelo | Director | June 30, 2014 A | 499,891 | 0 | 0 | $0 |
| Paul A. Bottomley | Director | Dec. 31, 2013 A | 144,622 | 0 | 0 | $0 |
| James K. Malernee Jr. | Director | Dec. 31, 2013 A | 378,722 | 0 | 0 | $0 |
| Bruce C. Conway | Director | March 22, 2013 P | 17,500 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 13 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.40% | 7,917 SH | Oct. 2, 2026 | Daily |
| IBRN · iShares Trust | 0.38% | 2,096 SH | Sept. 11, 2026 | Daily |
| IWC · iShares Trust | 0.09% | 96,092 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 30,234 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 264,730 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 162,216 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 13,451 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 723,424 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 351,874 SH | Aug. 19, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 10,951 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 34,601 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 853,804 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,134 SH | Aug. 19, 2026 | Daily |
CLPT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$23.50
+115.7%
3 37.5%
Strong Buy
4 50.0%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-30Mean target $23.50 +115.7%
← Below all targets
Current price $10.89
Low$22.00
Mean$23.50
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| MOBI | · | · | · | · | · | · |
| TMCI | · | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 3, 2026